Clean Energy Technologies, Inc. (CETY) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on April 24, 2025, covering events occurring on April 23, 2025. Clean Energy Technologies, Inc. (the "Company"), a Nevada corporation listed on The Nasdaq Stock Market LLC, entered into a material definitive agreement to raise capital through a hybrid equity and debt transaction.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale of a convertible promissory note and common stock.
- Investor: Pacific Pier Capital II, LLC.
- Aggregate Purchase Price: $230,400.00.
- Net Proceeds to Company: $223,400 (after deducting $7,000 in legal expenses paid from gross proceeds).
- Debt Instrument: Convertible promissory note with a principal amount of $256,000.
- Equity Instrument: 45,000 shares of Company common stock.
- Note Terms: 12-month maturity; 10% annual interest; convertible after 6 months at 90% of the lowest VWAP during the 5 trading days prior to conversion.
Material Changes and Restrictions
The filing discloses the creation of a direct financial obligation and the unregistered sale of equity securities. The transaction is subject to specific covenants and restrictions:
- Use of Proceeds: Restricted to business development and payment of service providers. Explicitly prohibited for repayment of indebtedness to officers, directors, or employees, or for loans to affiliates.
- Exchange Cap: Issuance of shares to the investor is capped at 1,250,000 shares until shareholder approval is obtained.
- Beneficial Ownership Limit: Conversion is restricted if it would cause the holder to exceed 4.99% of outstanding common stock.
- Regulatory Filing: The Company must file a preliminary information statement on Schedule 14C by April 30, 2025, to seek shareholder approval for shares exceeding the Exchange Cap.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, revenue outlook, or management commentary regarding future performance. The primary risks identified are contingent on the terms of the agreement:
- Dilution Risk: The convertible note features a discount conversion price (90% of VWAP), which may result in significant dilution upon conversion.
- Shareholder Approval: Future issuance of shares beyond the 1,250,000 share cap is contingent on successful shareholder approval via Schedule 14C.
- Liquidity: The transaction provides immediate net liquidity of $223,400 but creates a debt obligation of $256,000 principal plus accrued interest.
Investor Verification Checklist
- Verify the Company's ability to file the required Schedule 14C by April 30, 2025.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) and Promissory Note (Exhibit 10.2) for additional covenants.
- Assess the impact of the 10% interest rate and potential dilution from the 90% conversion discount on existing shareholders.
- Confirm the Company's current cash position and whether the $223,400 net proceeds are sufficient for stated business development needs.
- Check for any subsequent filings regarding the shareholder vote on the Exchange Cap.